Individualized Medication Guidance for Gynecologic Cancer
This test detects 348 genes, and involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for gynecologic cancer patients.
Breast Cancer Prognosis Assessment
This test can aid in the development of breast cancer treatment plans and avoid conditions such as undertreatment or overtreatment.
Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, and involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.
The Disease Susceptibility Genetic Test-Anti-Cancer Package A
The test is based on biochip technology. By detecting susceptibility loci in the TP53 gene that are closely related to tumorigenesis, it evaluates its influence on the risk of male tumors and female tumors.
Mycobacteria Species Identification
The rapid identification of 17 clinically important mycobacterial species enables precise targeting of pathogenic strain types.